Perspective Therapeutics Inc (NYSEAMERICAN: CATX) stock closed at $3.19 on 10/20/25 after a major decline of -29.0%. Moreover, trading volume in this decline was exceptionally high at 559% of normal. The stock has declined -34.4% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Perspective Therapeutics has a current Value Trend Rating of A (Highest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Perspective Therapeutics has a good Appreciation Score of 76 and a good Power Rating of 79, and the Highest Value Trend Rating results.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment